Require Prescription
Description:
Zometa 4mg Vial/5ml is an intravenous bisphosphonate medication used primarily in the treatment of osteoporosis and bone metastases from certain types of cancer. It is administered as a solution for infusion.
Ingredients:
Active ingredient: Zoledronic acid Other ingredients: Mannitol, sodium citrate, etc. (excipients used in the formulation)
Usage Instructions:
Zometa is administered intravenously by a healthcare professional. The dosage and frequency depend on the condition being treated and the patient's specific medical profile. Typically, it is given once every 3 to 4 weeks for bone metastases and less frequently for osteoporosis.
Benefits:
- Treatment of osteoporosis by increasing bone mass and reducing the risk of fractures
- Management of bone metastases to reduce complications and pain
Precautions:
- Patients should be adequately hydrated before and after administration to reduce the risk of kidney problems.
- Monitoring of kidney function is essential during treatment.
- Zometa may interact with other medications; consult healthcare provider for guidance.
Storage Instructions:
- Store Zometa vials at controlled room temperature (25°C/77°F).
- Protect from light and moisture.
Manufacturer:
Novartis Pharmaceuticals
